Clin2
NCT06088472Possibly a fitRecruiting

TIL therapy for advanced solid tumors

Solid Tumors, Adult

Part of Cancer clinical trials.

This trial tests a treatment made from your own immune cells (TILs) that are taken from a tumor, grown in a lab, and then given back to you to fight cancer. It's for people with solid tumors that have spread or come back after treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You have a solid tumor that cannot be completely removed by surgery or has spread to other parts of the body.
  • You have at least one tumor (preferably in a lymph node near the skin) that can be surgically removed to make the treatment.
  • You have not had radiation or other local treatments on the tumor that will be removed.
  • You do not have untreated brain tumors causing symptoms.
  • You do not have an active autoimmune disease or need high-dose steroids.
  • You have not had a blood clot in the past 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05087745Recruiting· Early Phase 1
TIL therapy for advanced solid tumors

This trial tests a treatment that uses your own immune cells, called TILs, to fight advanced solid tumors. The cells are taken from a biopsy of your tumor, multiplied in a lab, and then given back to you. It might help if you have tried other treatments without success, or if no standard treatment is available.

Hangzhou, Zhejiang
NCT07294872Not yet recruiting· Phase 1
TIL therapy for advanced solid tumors

This trial tests a treatment using your own immune cells (TILs) to fight advanced solid tumors. If you have a tumor that can be removed to make the TILs, and you've tried other treatments without success, you may be eligible.

Chengdu
NCT04967833Recruiting· Early Phase 1
Testing TIL cell therapy for advanced solid tumors

This trial tests a type of immune cell treatment called TIL (tumor-infiltrating lymphocytes) in people with advanced solid cancers. It may help your immune system better recognize and attack tumors, especially if standard treatments have not worked.

Shanghai
NCT06488950Recruiting· Early Phase 1
TIL therapy for advanced solid tumors

This trial tests a new type of personalized cell therapy (TIL) for people with advanced solid tumors who have run out of standard treatment options. It aims to see if this approach can help shrink tumors.

Shanghai
NCT03658785Recruiting· Phase 1/Phase 2
Immunotherapy for advanced solid tumors using patient tumor cells

This trial tests an immunotherapy made from your own tumor-fighting immune cells (TIL). It may help people with advanced solid cancers that cannot be cured with surgery or radiation.

Wuhan, Hubei
NCT05971576Not yet recruiting· Early Phase 1
TIL cell therapy for advanced solid tumors

This early-stage trial tests a type of immune cell treatment (TILs) made from your tumor to treat advanced solid cancers. It may help if standard treatments have failed or aren’t an option, but you must be able to provide enough tumor tissue for cell collection.

Hear when a new Solid Tumors, Adult trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.